Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03051204 · ClinicalTrials.gov registry record
OptiCal Study -Optimizing Fecal Calprotectin Monitoring: a Clinical Study Comparing CalproLab Against PhiCal and Evaluating Its Association With the Gut Microbiome
A clinical trial, sponsored by University of California, Los Angeles.
- Completed
- Registry status
- 175
- Enrollment target
NCT03051204 is a clinical trial that has completed, run by University of California, Los Angeles. The registered enrollment target is 175 participants.
The verdict
NCT03051204 has completed, sponsored by University of California, Los Angeles.
- COMPLETED
- Registry status
- 175 participants
- Enrollment target
Study Summary
Study Aims: To analyze stool specimens to test and validate the CalproLab assay against the predicate PhiCal in order to determine performance characteristics. And to correlate Calpro levels to the gut microbiome composition.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 175 participants |
| Start Date | 2017-02-28 |
| Est. Completion | 2018-12-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03051204
The ClinicalTrials.gov registry entry for NCT03051204 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 175 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT03051204 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03051204 about?
NCT03051204 is a clinical study titled "OptiCal Study -Optimizing Fecal Calprotectin Monitoring: a Clinical Study Comparing CalproLab Against PhiCal and Evaluating Its Association With the Gut Microbiome". Study Aims: To analyze stool specimens to test and validate the CalproLab assay against the predicate PhiCal in order to determine performance characteristics. And to correlate Calpro levels to the gut microbiome composition.
What is the current status of trial NCT03051204?
This trial is currently completed. The enrollment target is 175 participants. The study started on 2017-02-28. Estimated completion is 2018-12-11.
Who is sponsoring clinical trial NCT03051204?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.